Glutamate is not involved in the MPP+-induced dopamine overflow in the striatum of freely moving C57BL/6 mice

Journal of Neurology

Volumn 248, Issue 9, 2001, Pages 899-908

  Uezono, T ^a   Matsubara, K ^a   Shimizu, K ^a   Mizukami, H ^a   Ogawa, K ^a   Saito, O ^a   Hayase, N ^a   Eto, H ^b   Kimura, K ^b   Shiono, H ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Dopamine overflow; Glutamate; MPP+; NMDA antagonist; Striatum

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; DIZOCILPINE; DOPAMINE; GLUTAMIC ACID; N METHYL 4 PHENYLDIHYDROPYRIDINIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; HORMONE RELEASE; HORMONE TRANSPORT; MALE; MICRODIALYSIS; MOUSE; NEUROTRANSMISSION; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RECEPTOR BLOCKING; TOXICITY;

EID: 0034876920     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
2. Glutamate and Parkinson's disease
3. +)
4. + elimination in the mouse striatum
5. (+)-MK-801 does not prevent MPTP-induced loss of nigral neurons in mice
6. +, a metabolite of MPTP, by brain synaptosomes
7. +: Possible action at the dopamine transporter
8. +-induced neurotoxicity in mouse is age-dependent: Evidenced by the selective inhibition of complexes of electron transport
9. The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro
10. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
11. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
12. Cell death induced by β-amyloid 1-40 in MES 23.5 hybrid clone: The role of nitric oxide and NMDA-gated channel activation leading to apoptosis
13. + and β-carbolinium in the striatum of conscious rats
14. Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter
15. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals
16. A removal brain microdialysis probe units for in vivo monitoring of neurochemical activity
17. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
18. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced
19. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium
20. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria
21. +)
22. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia
23. +) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon
24. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: A microdialysis study
25. Reduced dorsal hippocampal glutamate release significantly correlates with the spatial memory deficits produced by benzodiazepines and ethanol
26. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats
27. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice
28. + neurotoxicity by N-methyl-D-aspartate antagonists